Efficacy and Safety of Intravenous Solanezumab in Patients with Mild to Moderate Alzheimer's Disease: Results of Two Phase 3 Studies

Poster Number: NR 14 Efficacy and Safety of Intravenous Solanezumab in Patients with Mild to Moderate Alzheimer’s Disease: Results of Two Phase 3 Studies Ann M. Hake, MD; Eric Siemers, MD; Christopher Carlson, PhD; Wahiba Estergard, PharmD; Karen Sundell, BS; David Henley, MD; Jennifer Eads, PharmD; Cora Sexton, BSN; Robert A. Dean, PhD, MD; Brian Willis, PhD; Ronald DeMattos, PhD; Richard Mohs, PhD